Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B - Wikidata - wikimedia - TriplyDB

Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B

Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B

http://www.wikidata.org/entity/Q35075772

about

Clostridium difficile spore biology: sporulation, germination, and spore structural proteins Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile Hard surface biocontrol in hospitals using microbial-based cleaning products Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A Clostridium difficile infection: New insights into therapeutic options.An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.Mucosal adjuvant activity of IL-2 presenting spores of bacillus subtilis in a murine model of Helicobacter pylori vaccination.High-throughput analysis of gene essentiality and sporulation in Clostridium difficile The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.Recurrent Clostridium difficile infection: From colonization to cure.Recombinant Bacillus subtilis Spores Elicit Th1/Th17-Polarized Immune Response in a Murine Model of Helicobacter pylori Vaccination.Breakthroughs in the treatment and prevention of Clostridium difficile infection.Recombinant lipoprotein-based vaccine candidates against C. difficile infections.Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis.A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies.Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.Functional characterization of Clostridium difficile spore coat proteins.Protective efficacy induced by recombinant Clostridium difficile toxin fragments Characterization of the spore surface and exosporium proteins of Clostridium sporogenes; implications for Clostridium botulinum group I strains.Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.Immunization strategies for Clostridium difficile infections.Vaccines against Clostridium difficile.Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.Recent progress in Bacillus subtilis spore-surface display: concept, progress, and future.The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore.The alternative sigma factor σB plays a crucial role in adaptive strategies of Clostridium difficile during gut infection.Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.The spore-associated protein BclA1 affects the susceptibility of animals to colonization and infection by Clostridium difficile.Therapeutic approaches for Clostridium difficile infections.Biological Containment of Genetically Modified Bacillus subtilis.The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile.The role of toxins in Clostridium difficile infection.

P2860

Q27021014-890774BD-5CAF-4E7D-9586-E567A0690BFB Q27680788-A2B9BDB7-2D64-4032-B417-55F9A43F5C7E Q28543303-A4C0B935-699B-4D27-BCFA-CD3DB1CD1D99 Q28547242-4FED9952-6B6E-4D3F-87E8-0A0907282FAD Q30252154-4A52B617-2056-4B89-83C1-A68629D43545 Q34298763-BF0E7BB9-0A2B-4FFC-B3B8-53C48E50C4EC Q34315655-475A3D20-1F58-459C-A940-09896346D9FA Q35152187-24459550-A05E-4009-84F9-EFEA80E62A8E Q35567539-8CD6B659-BD1C-41C0-B131-5A64B3ED525B Q35577842-FB15F8A9-1E4A-4D3B-BED6-64F16DE66A5B Q35773934-98F1F15C-F9FE-4AF1-990E-BEF2C960FBB0 Q35822541-30A66406-CD12-4A25-B017-B0D17B590CBB Q35856089-53AD5621-3A46-4F0D-90B2-1B03214F5910 Q35918566-B825D24B-6E3B-4DE5-B2BB-DAEF7674A827 Q35923218-F760BFA4-C22E-4800-A7AE-6E7E8F02E95F Q36019350-0BD8D25A-1C5F-4A86-8234-A250FE7A6A15 Q36190012-D4FBE3F2-C4F1-4911-87D5-398DF1F4A719 Q36208249-94480BA0-E7E6-490D-B594-9C652CA8AB97 Q36211064-A5BAD20A-5E0E-431B-B65E-A8A88A16AA34 Q36255845-398F5713-C98C-4E11-A719-69220E93B742 Q36379304-20D2A8AA-9452-427F-9DDE-ED3CF0277E7D Q36410918-8C9A7EAC-2020-4DF5-9FED-562B4841CA9C Q36760571-49622A69-04D9-4C7B-A0DA-644758336771 Q37036112-2E0EACA2-CDDE-4803-8C8C-11959A8B1018 Q37088993-C30DBD5A-853A-4D17-96D4-5AD48A828CC8 Q37123637-57C69961-81C7-4BF6-81C3-D7F0CB3E2B0B Q37671489-D92C28AF-D5D3-4EE0-BD62-4D71AEB35BAD Q38006996-AF1F4548-7EF8-404F-B6D3-6ED66B8127E7 Q38196682-775C0CB3-8ECD-4B06-898C-58E28D160107 Q38717600-D70AB057-F741-4262-A035-87A3401ECBA6 Q38773648-FCF06CB4-65C2-4143-A604-617E38BDDCF8 Q40050837-BB78698A-1CC6-4690-90D6-5A34C2929E44 Q40332943-EB62C685-3F9A-435B-BF0B-055255908512 Q40899692-35D72011-6DED-4FBB-A5FC-C429BAC64EA1 Q41990887-D0D75AD7-FBCD-4036-BD0F-48FDBECCAA4F Q42219908-74C20769-E124-4505-927E-6890250CC580 Q45406068-D468A34D-165C-44C9-A401-6FA87FFF043F Q46259284-088C6E91-D83E-4DD5-BFFE-2BD70081EF48 Q47714859-55DD9E52-23C0-404E-9C0E-17AE0D1304CC Q47734724-47BEE3B6-E39F-4475-A788-D37C27BB553B

P2860

Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B

http://www.wikidata.org/entity/Q35075772

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunization with Bacillus spo ...... rains producing toxins A and B

@ast

Immunization with Bacillus spo ...... rains producing toxins A and B

@en

type

label

Immunization with Bacillus spo ...... rains producing toxins A and B

@ast

Immunization with Bacillus spo ...... rains producing toxins A and B

@en

prefLabel

Immunization with Bacillus spo ...... rains producing toxins A and B

@ast

Immunization with Bacillus spo ...... rains producing toxins A and B

@en

P1433

Q35075772-4BF67CDC-58D2-4161-98B1-F392D639D6EF

P1476

Q35075772-09F9ED32-ACBE-43A8-BB33-F9F7B5250DFE

P2093

Q35075772-383A4992-2925-4729-9849-A17878C1EC6E

Q35075772-7947AFE8-9909-46C6-ADC7-D965FDDF4152

Q35075772-863742CC-0405-410A-8AD5-92B6623049D6

Q35075772-8FB7FEBE-B48B-4EB1-9AB8-8A5E2BBBF93F

Q35075772-93937F1D-210B-4B8B-906B-31EA6FD3BD44

Q35075772-AC72896E-A4FC-4DA1-A490-3439EDA33C3B

Q35075772-E310C26C-1C0C-45C3-959B-86BDA78CD847

P2860

Q35075772-00F67D5A-E0B5-4137-A9AE-BDCC71E0E111

Q35075772-11B5AFD8-DB2D-4360-9CD6-4B399C09BA07

Q35075772-2D703BBC-09A4-4C38-9F93-F5D8E5C5839E

Q35075772-4004E81A-DE5C-436F-A3A8-B6F1083B0339

Q35075772-4454EB4E-FFC1-4444-AF89-ECA924C3FDBF

Q35075772-44BD7E87-136E-4212-8701-076440E85615

Q35075772-4A7DB821-15B8-460F-8BBA-FB16D0EBE730

Q35075772-511467B5-97EA-429F-93FD-BA32455E6A1D

Q35075772-5237EF52-75C7-4053-A8C6-DC0B863130A0

Q35075772-5BD09386-1436-49EA-B348-37EB9DD5D516

P304

Q35075772-055A222D-86B9-4C1D-91D5-00E92C16752D

P31

Q35075772-1B49DA79-782B-4F57-93E7-C65031A7B549

P356

Q35075772-D49D131D-04C9-4256-B627-E611704DA89E

P407

Q35075772-1B5F1F6E-DC35-495F-B4C3-1439F5D37ED9

P433

Q35075772-7E484ABA-9297-456A-8177-3B9C03FF2298

P478

Q35075772-FA0B847A-CFA9-4412-A04D-11C81AEED9F7

P577

Q35075772-B5BB89AE-5464-454E-A0A8-0856AB9DD39C

P698

Q35075772-797A9460-05EB-46CB-A303-FC689405D806

P921

Q35075772-2ED6573D-A114-4B5D-9A64-EAC093D63A18

Q35075772-CF595D50-04D2-44C5-BE00-327C285A78B5

P932

Q35075772-32143EA1-6E32-462C-A42C-8E2EBC80B965

P356

P1433

Infection and Immunity

P1476

Immunization with Bacillus spo ...... rains producing toxins A and B

@en

P2093

Huynh A Hong

http://www.w3.org/2001/XMLSchema#string

Jen-Min Huang

http://www.w3.org/2001/XMLSchema#string

Jenny Cook

http://www.w3.org/2001/XMLSchema#string

Jutarop Phetcharaburanin

http://www.w3.org/2001/XMLSchema#string

Neil F Fairweather

http://www.w3.org/2001/XMLSchema#string

Patima Permpoonpattana

http://www.w3.org/2001/XMLSchema#string

Simon M Cutting

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile toxins: mechanism of action and role in disease.

Clostridium difficile: its disease and toxins

Toxin B is essential for virulence of Clostridium difficile

Molecular characterization of the Clostridium difficile toxin A gene

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Surface display of recombinant proteins on Bacillus subtilis spores.

Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.

P304

2295-2302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00130-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21482682

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3125831

http://www.w3.org/2001/XMLSchema#string